Marsh, Robyn L.
Nelson, Maria T.
Pope, Chris E.
Leach, Amanda J.
Hoffman, Lucas R.
Chang, Anne B.
Smith-Vaughan, Heidi C.
Funding for this research was provided by:
National Health and Medical Research Council (GNT1040830, GNT1078557, 1034703, 1058213, 1020561, GNT1131932)
National Institutes of Health (R01DK095869, 1R01NS095979-01)
Article History
Received: 15 January 2018
Accepted: 21 June 2018
First Online: 5 July 2018
Ethics approval and consent to participate
: Not applicable
: Not applicable
: LRH declares he has received support for investigator-initiated studies from Novartis and Vertex on topics described in this article. As Director of the Center for Cystic Fibrosis Microbiology, LRH provides consultation for private and academic entities designing studies of new respiratory therapies. All other authors declare they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.